Geneva Partners, LLC Abbott Laboratories Transaction History

Geneva Partners, LLC

$239 Million
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$109.52 - $120.96 $78,963 - $87,212	-721 Reduced 17.44%	3,414 $388,000
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $230,164 - $281,740	-2,552 Reduced 38.16%	4,135 $455,000
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $448,417 - $538,026	-4,694 Reduced 41.24%	6,687 $647,000
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $10,078 - $11,229	-100 Reduced 0.87%	11,381 $1.24 Million
Q1 2023 Apr 26, 2023	SELL	$96.86 - $114.01 $256,679 - $302,126	-2,650 Reduced 18.75%	11,481 $1.16 Million
Q4 2022 Jan 23, 2023	SELL	$95.06 - $111.52 $237,554 - $278,688	-2,499 Reduced 15.03%	14,131 $0
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $101,598 - $117,631	-1,050 Reduced 5.94%	16,630 $604,000
Q2 2022 Jul 25, 2022	SELL	$102.07 - $123.37 $2.83 Million - $3.42 Million	-27,688 Reduced 61.03%	17,680 $1.92 Million
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $1.26 Million - $1.54 Million	-11,070 Reduced 19.61%	45,368 $5.37 Million
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $186,812 - $228,740	1,617 Added 2.95%	56,438 $7.94 Million
Q3 2021 Oct 18, 2021	BUY	$116.66 - $129.06 $1.03 Million - $1.14 Million	8,868 Added 19.3%	54,821 $6.48 Million
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $69,292 - $81,567	-655 Reduced 1.41%	45,953 $5.33 Million
Q1 2021 May 05, 2021	SELL	$108.84 - $128.23 $245,325 - $289,030	-2,254 Reduced 4.61%	46,608 $5.59 Million
Q4 2020 Feb 01, 2021	SELL	$105.0 - $114.42 $798,420 - $870,049	-7,604 Reduced 13.47%	48,862 $5.35 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $93,014 - $112,959	-1,015 Reduced 1.77%	56,466 $6.15 Million
Q2 2020 Jul 20, 2020	BUY	$76.57 - $98.0 $680,783 - $871,318	8,891 Added 18.3%	57,481 $5.26 Million
Q1 2020 Apr 27, 2020	BUY	$62.82 - $91.86 $777,334 - $1.14 Million	12,374 Added 34.17%	48,590 $3.83 Million
Q4 2019 Feb 04, 2020	BUY	$78.51 - $87.4 $323,853 - $360,525	4,125 Added 12.85%	36,216 $3.15 Million
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $112,038 - $121,485	-1,369 Reduced 4.09%	32,091 $2.69 Million
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $35,565 - $41,480	-488 Reduced 1.44%	33,460 $2.81 Million
Q1 2019 May 10, 2019	BUY	$66.22 - $80.06 $192,700 - $232,974	2,910 Added 9.38%	33,948 $2.71 Million
Q4 2018 Jan 30, 2019	SELL	$65.56 - $74.27 $124,564 - $141,113	-1,900 Reduced 5.77%	31,038 $2.25 Million
Q3 2018 Oct 23, 2018	BUY	$60.81 - $73.36 $13,682 - $16,506	225 Added 0.69%	32,938 $2.42 Million
Q2 2018 Aug 09, 2018	SELL	$57.57 - $63.54 $54,691 - $60,363	-950 Reduced 2.82%	32,713 $2 Million
Q1 2018 May 08, 2018	BUY	$56.27 - $63.62 $67,524 - $76,344	1,200 Added 3.7%	33,663 $2.02 Million
Q4 2017 Feb 08, 2018	BUY	$53.68 - $57.47 $21,472 - $22,988	400 Added 1.25%	32,463 $1.85 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $1.54 Million - $1.72 Million	32,063	32,063 $1.71 Million

Others Institutions Holding ABT

# of Institutions

3,137

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

Vanguard Group Inc Valley Forge, PA

166M
Shares

$18.7 Billion
0.34% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$14.8 Billion
0.31% of portfolio
State Street Corp Boston, MA

74.4M
Shares

$8.38 Billion
0.34% of portfolio
Capital International Investors Los Angeles, CA

71.8M
Shares

$8.09 Billion
1.57% of portfolio
Capital Research Global Investors Los Angeles, CA

57.2M
Shares

$6.45 Billion
1.34% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Partners, LLC with notifications on news.

Account